With global CBD sales potentially hitting $22 billion by 2022, here are four CBD stocks you'll want to know about.
News & Analysis: CV Sciences, Inc.
In a month where pot stocks mostly treaded water, these six advanced by at least 23%.
Two hemp stocks. One clear winner.
The gains Zscaler, lululemon athletica, and CV Sciences have put up over the past 12 months can't be ignored.
These 3 Stocks Trounced the Top Marijuana ETFs in 2018, and Here's Why They'll Do It Again This Year
Repeat performances could be in store for these big marijuana winners from last year.
These top-performing pot stocks at least doubled in value during a very challenging year.
Hemp is now legal in the U.S. Here are three stocks that should be big winners.
These U.S. stocks have skyrocketed this year. But can the good times keep rolling into 2019?
There's a not-so-green side to pot stocks you may not be aware of.
What investors need to watch at CannaVEST